Skip to main content
Przejdź do strony domowej Komisji Europejskiej (odnośnik otworzy się w nowym oknie)
polski pl
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
Zawartość zarchiwizowana w dniu 2024-06-18

Deciphering mycobacterial subversion of early steps of adaptive immunity in vivo: A new approach to solve an old problem

Cel

"Tuberculosis (TB) is a disease caused by Mycobacterium tuberculosis (Mtb) and currently one third of the world’s population is latently infected with Mtb, in spite of the existence of a vaccine. This scenario is in part due to Mtb’s ability to adapt to current treatments, e.g. development of multi-resistance to antibiotics. However we also lack a proper understanding of the immunological mechanisms subverted by Mtb to establish a chronic infection and the reasons for the failure of the current vaccine to provide protection. Hence, new cross-disciplinary approaches are required to identify at what level Mtb virulence factors or the current vaccine strain prevent the induction of a protective immune response.
Here we will identify the mechanisms by which mycobacterium strains subvert T cell immunity that is critical for the protection from fatal infection. We will do this in the context of an infection with virulent Mtb and vaccination with the current vaccine strain (BCG) or a new attenuated Mtb strain that is a promising candidate for a new TB vaccine. To this purpose we will investigate a critical step for the initiation of T cell immunity against mycobacteria, the migration of infected dendritic cells to the draining lymph node.
Our approach will make use of unique tools to gain new insights into the interaction between host factors and mycobacteria virulence factors. These include novel intravital multiphoton microscopy studies of the infectious process in the lung and cross-disciplinary approaches such as a high-throughput screen of a library of Mtb mutants for regulators of dendritic cell function.
This research proposal will benefit from the unique synergy between the expertise in mycobacterium’s biology of the host institution and my immunological expertise of T cell immunity. Therefore, we foresee making significant contributions that will be instrumental for the development of new vaccines and more efficient treatments of TB."

Dziedzina nauki (EuroSciVoc)

Program(-y)

Temat(-y)

Zaproszenie do składania wniosków

FP7-PEOPLE-2011-IIF
Zobacz inne projekty w ramach tego zaproszenia

System finansowania

MC-IIF - International Incoming Fellowships (IIF)

Koordynator

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
Wkład UE
€ 269 096,40
Koszt całkowity
Brak danych